Key points are not available for this paper at this time.
The article presents the results of the research for the new challenges of today regarding the incidence of monkeypox virus using organizational and legal, clinical and pharmacological approaches to analyze epidemiology, risks, symptoms, vaccination opportunities, recommendations for detection, pharmacotherapy and prevention. Complex experimental organizational and legal, clinical a n d pharmacological study was conducted. The research was conducted on the basis of the disciplines of healthcare organization, pharmacy organization and management, forensic pharmacy, clinical pharmacy, management for different groups of patients and was based on the principles of evidence-based medicine, evidence-based pharmacy. Issues of epidemiology, risks, symptoms, vaccination of monkeypox disease were studied. Recommendations of the WHO and scientific circles concerning the effectiveness of detection, pharmacotherapy, and prevention of monkeypox were analyzed.
Вікторія Шаповалова (Wed,) studied this question.